PRVA logo

Privia Health Group Inc. (PRVA)

$21.12

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on PRVA

Market cap

$2.70B

EPS

0.22

P/E ratio

96

Price to sales

1.14

Dividend yield

--

Beta

0.850062

Price on PRVA

Previous close

$21.20

Today's open

$21.22

Day's range

$21.04 - $21.35

52 week range

$19.53 - $28.82

Profile about PRVA

CEO

Parth Mehrotra

Employees

1226

Headquarters

Arlington, VA

Exchange

Nasdaq Global Select

Shares outstanding

127734207

Issue type

Common Stock

PRVA industries and sectors

Healthcare

Healthcare Providers & Services

News on PRVA

Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors

ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D.

news source

GlobeNewsWire • Aug 18, 2026

news preview

Privia Health Group Q2 Earnings Call Highlights

Privia Health Group NASDAQ: PRVA reported second-quarter results marked by double-digit growth in implemented providers, attributed lives and practice collections, while adjusted EBITDA rose 29% from a year earlier. Management also raised its 2026 outlook for several financial measures following what Chief Executive Officer Parth Mehrotra described as strong first-half execution.

news source

MarketBeat • Aug 7, 2026

news preview

Privia Health Group, Inc. (PRVA) Q2 2026 Earnings Call Transcript

Privia Health Group, Inc. (PRVA) Q2 2026 Earnings Call Transcript

news source

Seeking Alpha • Aug 6, 2026

news preview

Privia Health Reports Strong Second Quarter and Year-to-Date 2026 Results

2Q'26 Net Income of $9.0M, +236.7% from 2Q'25 2Q'26 Adjusted EBITDA of $37.4M, +29.1% from 2Q'25 Full-Year 2026 Guidance Raised for All Key Financial Metrics ARLINGTON, Va., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the second quarter and six-month periods ended June 30, 2026.

news source

GlobeNewsWire • Aug 6, 2026

news preview

Compared to Estimates, Privia Health (PRVA) Q2 Earnings: A Look at Key Metrics

Although the revenue and EPS for Privia Health (PRVA) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

news source

Zacks Investment Research • Aug 6, 2026

news preview

Privia Health (PRVA) Misses Q2 Earnings Estimates

Privia Health (PRVA) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.02 per share a year ago.

news source

Zacks Investment Research • Aug 6, 2026

news preview

What Does a Privia Health Insider's Sale of Company Shares for $3.6 Million Mean for Investors?

Former CEO Shawn Morris sold 135,498 shares on June 30 and July 1, 2026, generating proceeds of ~$3.57 million at a weighted average price around $26.32 per share. Morris' sale reduced direct ownership to 76,651 shares post-transaction.

news source

The Motley Fool • Jul 12, 2026

news preview

Privia Health to Report Second Quarter 2026 Results on Thursday, August 6

ARLINGTON, Va., July 07, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its second-quarter and six-month periods ended June 30, 2026 before market open on Thursday, August 6, 2026.

news source

GlobeNewsWire • Jul 7, 2026

news preview

Privia's CEO Just Sold 121,000 Shares for $2.7 Million

CEO Parth Mehrotra sold 121,086 shares directly for a total of ~$2.73 million at an average price of around $22.56 per share across two days ending May 12, 2026. This transaction represented 21.80% of Mehrotra's direct holdings prior to the sale, reducing his direct position to 434,357 shares.

news source

The Motley Fool • Jun 8, 2026

news preview

Cross Keys Capital Advises Neurology Group of Bergen County in Its Partnership with Privia Health

Fort Lauderdale, May 28, 2026 (GLOBE NEWSWIRE) -- Cross Keys Capital, LLC, a leading independent investment banking firm providing M&A advisory services to physician group practices and healthcare services companies,is  pleased to announce it acted as the exclusive financial advisor to the Neurology Group of Bergen County (“NGBC”) in its partnership with Privia Health. Founded in 1973, the Neurology Group of Bergen County is one of the region's most respected independent neurology practices, serving the communities of Bergen County, New Jersey.

news source

GlobeNewsWire • May 28, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Privia Health Group Inc.

Open an M1 investment account to buy and sell Privia Health Group Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in PRVA on M1